Sinha Sanjeev, Guleria R, Misra A, Pandey R M, Yadav R, Tiwari Sumit
Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Indian J Med Res. 2004 Feb;119(2):66-71.
BACKGROUND & OBJECTIVES: The purpose of this study was to evaluate pulmonary functions including respiratory muscle strength in patients with type 2 diabetes mellitus (T2DM) and to determine their correlations with anthropometric profile, glycaemic control, and microangiopathic diabetic complications.
Twenty nine patients with T2DM and 11 healthy control subjects were divided into the following three groups; (i) T2DM patients with any or a combination of microangiopathy(ies) (retinopathy, nephropathy, and peripheral neuropathy) (group 1, n=12); (ii) T2DM patients without any complications (group 2, n = 17); and (iii) a healthy control group (group 3, n=11). All patients were assessed with anthropometry, glycosylated haemoglobin (HbA1C), and lipid profile. Pulmonary functions were measured by spirometry. Pulmonary diffusion capacity for carbon monoxide (DLco) was measured by the steady state method. The presence of diabetic nephropathy was determined by 24 h protein excretion.
A significant reduction of DLco was observed in group 1 (P<0.001), as compared to the other groups. There were no differences among the three groups for other pulmonary functions; forced vital capacity, forced expired volume in one second, peak expiratory flow rate, and maximal static inspiratory and expiratory pressures. Significant correlations were observed between DLco and the following parameters in group 1; HbA1c (r=0.62, P<0.05), total cholesterol level (r = -0.44, P<0.05) and creatinine clearance (r=0.42, P<0.05).
INTERPRETATION & CONCLUSION: The present study shows that the impairment of pulmonary diffusion capacity for carbon monoxide was common in T2DM Asian Indian patients having microangiopathy. Pathophysiologically, it could be related to glycaemic control or dyslipidaemia. Correlation of % BF with DLCo needs to be explored further.
本研究旨在评估2型糖尿病(T2DM)患者的肺功能,包括呼吸肌力量,并确定其与人体测量学特征、血糖控制及微血管性糖尿病并发症之间的相关性。
29例T2DM患者和11名健康对照者被分为以下三组:(i)患有任何一种或多种微血管病变(视网膜病变、肾病和周围神经病变)的T2DM患者(第1组,n = 12);(ii)无任何并发症的T2DM患者(第2组,n = 17);以及(iii)健康对照组(第3组,n = 11)。所有患者均接受人体测量、糖化血红蛋白(HbA1C)和血脂谱评估。通过肺量计测量肺功能。采用稳态法测量一氧化碳肺弥散量(DLco)。通过24小时尿蛋白排泄量确定糖尿病肾病的存在。
与其他组相比,第1组观察到DLco显著降低(P < 0.001)。三组在其他肺功能指标上无差异;用力肺活量、一秒用力呼气容积、呼气峰值流速以及最大静态吸气和呼气压力。在第1组中,观察到DLco与以下参数之间存在显著相关性;HbA1c(r = 0.62,P < 0.05)、总胆固醇水平(r = -0.44,P < 0.05)和肌酐清除率(r = 0.42,P < 0.05)。
本研究表明,在患有微血管病变的T2DM亚洲印度患者中,一氧化碳肺弥散功能受损较为常见。从病理生理学角度来看,这可能与血糖控制或血脂异常有关。需要进一步探讨体脂百分比与DLCo之间的相关性。